title: Management of the thrombocytopenic cardiac surgical patient--a role for aprotinin?
authors.affiliation: Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center, Dallas 75235-9068.
authors.forename: C W
authors.initials: CW
authors.lastname: Whitten
authors.forename: P M
authors.initials: PM
authors.lastname: Allison
authors.forename: T W
authors.initials: TW
authors.lastname: Latson
authors.forename: R F
authors.initials: RF
authors.lastname: Bossard
authors.forename: J A
authors.initials: JA
authors.lastname: Rosenberg
authors.forename: W S
authors.initials: WS
authors.lastname: Ring
mesh_terms: D000368:Aged; D007611:Aprotinin / Q000627:therapeutic use*; D016063:Blood Loss, Surgical; D006350:Heart Valve Prosthesis; D006470:Hemorrhage / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008943:Mitral Valve / Q000601:surgery; D011183:Postoperative Complications / Q000188:drug therapy; D011300:Preoperative Care; D013921:Thrombocytopenia / Q000150:complications*
chemical_list: D007611:Aprotinin